Nectar Lifesciences Limited — JV/Acquisition, 06-03-2026: Acquisition

Nectar Lifesciences (NECLIFE) has finalized the acquisition of 100% paid-up equity in Avensis Exports Private Limited (AEPL) for ₹0.25 Cr, paid entirely in cash. This transaction immediately makes AEPL a Wholly Owned Subsidiary of NECLIFE. For investors, this means Nectar Lifesciences gains full operational control over AEPL, directly integrating its business into NECLIFE's existing framework. This move expands the company's operational footprint and portfolio without significant financial outlay.